Koyfin Home > Directory > Health Care > Revance Therapeutics > Total Revenue

Revance Therapeutics Total Revenue Chart (RVNC)

Revance Therapeutics annual/quarterly Total Revenue from 2012 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Revance Therapeutics Total Revenue for the quarter ending June 06, 2020 was $0m a 84.62% increase of 0m year over year
  • Revance Therapeutics Total Revenue for the last 12 months ending June 06, 2020 was $0m a -64.84% decrease of 0m year over year
  • Revance Therapeutics Annual Total Revenue for 2019 was $0m a -802.91% decrease of -3m from 2018
  • Revance Therapeutics Annual Total Revenue for 2018 was $4m a 92.97% increase of 3m from 2017
  • Revance Therapeutics Annual Total Revenue for 2017 was $0m a -14.50% decrease of 0m from 2016
Other Income Statement Metrics:
  • Revance Therapeutics EBITDA for the quarter ending December 12, 2018 was $-38m a 7.02% decrease of -3m year over year
  • Revance Therapeutics Net Income for the quarter ending September 09, 2018 was $-33m a -9.36% increase of 3m year over year
View Chart On Koyfin

Quarterly RVNC Total Revenue Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
03/2019$0m
12/2018$0m
09/2018$2m
06/2018$1m
03/2018$0m
12/2017$0m

Annual RVNC Total Revenue Data

2019$0m
2018$4m
2017$0m
2016$0m
2015$0m
2014$0m
2013$1m
2012$1m
2011$1m